Revisiting the Subtle Relationship Between Metabolic Syndrome and Osteoarthritis
Authors:
- Hong-Chen RenHRHong-Chen Ren
- Yu-Chen WangYWYu-Chen Wang
- Jing-Bo ChengJCJing-Bo Cheng
- Hai-Cheng TaoHTHai-Cheng Tao
- Hui FengHFHui Feng
- Ming-Li FengMFMing-Li Feng
Open Access
- 1 March 2026
- journal article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-15
Abstract
Osteoarthritis (OA) is a common disabling joint disorder traditionally attributed to mechanical wear. Emerging evidence shows that metabolic syndrome (MetS) and its components—obesity, hypertension, hyperglycemia, and dyslipidemia—are closely associated with OA onset and progression, suggesting that OA also has a metabolic-inflammatory nature. This review highlights mechanisms linking each MetS component to OA. Obesity contributes not only by increasing joint load but also through adipokines such as leptin, resistin, and visfatin, which activate inflammatory pathways and promote cartilage degradation and synovitis. Hypertension may worsen OA via joint ischemia, oxidative stress, and renin–angiotensin system activation. Hyperglycemia damages cartilage and ligaments by promoting advanced glycation end product accumulation and oxidative stress. Dyslipidemia influences OA through cholesterol deposition and inflammatory responses. Metabolic inflammation and immunometabolic reprogramming further drive OA progression. MetS and OA are interconnected through mechanical stress, adipokine activity, inflammatory signaling, and metabolic dysregulation. Future studies should clarify how MetS affects pain, subchondral bone remodeling, and other OA phenotypes, aiding the development of individualized, metabolism-targeted strategies for early intervention and comprehensive OA management.Keywords
This publication has 140 references indexed in Scilit:
- Metabolic Reprogramming in Stromal and Immune Cells in Rheumatoid Arthritis and Osteoarthritis: Therapeutic PossibilitiesEuropean Journal of Immunology, 2025
- Enhancement of Intracellular Cholesterol Efflux in Chondrocytes Leading to Alleviation of Osteoarthritis ProgressionArthritis & Rheumatology, 2024
- Evaluation and Treatment of Knee PainJAMA, 2023
- Circular RNA circARPC1B functions as a stabilisation enhancer of Vimentin to prevent high cholesterol‐induced articular cartilage degenerationClinical and Translational Medicine, 2023
- Association of Diabetes Mellitus Status and Hyperglycemia With Symptomatic Knee OsteoarthritisArthritis Care & Research, 2022
- Association of Serum Low‐Density Lipoprotein, High‐Density Lipoprotein, and Total Cholesterol With Development of Knee OsteoarthritisArthritis Care & Research, 2022
- Global Deletion of Pannexin 3 Resulting in Accelerated Development of Aging‐Induced Osteoarthritis in MiceArthritis & Rheumatology, 2021
- Using Cumulative Load to Explain How Body Mass Index and Daily Walking Relate to Worsening Knee Cartilage Damage Over Two Years: The MOST StudyArthritis & Rheumatology, 2020
- Adiponectin receptor agonist AdipoRon attenuates calcification of osteoarthritis chondrocytes by promoting autophagyJournal of Cellular Biochemistry, 2020
- Leptin induces MMP1/13 and ADAMTS 4 expressions through bone morphogenetic protein‐2 autocrine effect in human chondrocytesJournal of Cellular Biochemistry, 2017